/EVARF

EVARF Stock - Lombard Medical, Inc.

Q: What is the analyst price target for EVARF?

Analyst price target information is not currently available for EVARF.

Q: What is EVARF's market cap?

Market capitalization information is not currently available for EVARF.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EVARF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.25

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2016	FY2015
Revenue	$12.17M	$15.11M
Gross Profit	$955,000	$6.56M
Gross Margin	7.8%	43.4%
Operating Income	$-29,335,000	$-39,467,000
Net Income	$-31,035,000	$-37,804,000
Net Margin	-255.0%	-250.1%
EPS	$-1.54	$-2.13

Company Overview

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.

Visit Website

Earnings History & Surprises

EVARF

Beat Rate

67%

Last 6 quarters

Avg Surprise

+1.9%

EPS vs Estimate

Beats / Misses

4/2

Last 12 quarters

Latest EPS

$-0.37

Q4 2016

EPS Surprise History

Q4 14

+25.7%

$-0.52vs$-0.70

Q2 15

-1.7%

$-0.59vs$-0.58

Q3 15

+7.3%

$-0.51vs$-0.55

Q4 15

+15.1%

$-0.45vs$-0.53

Q2 16

+7.3%

$-0.38vs$-0.41

Q4 16

-42.3%

$-0.37vs$-0.26

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2018	Aug 24, 2018	—	—	—	—
Q2 2017	Apr 18, 2017	—	—	—	—
Q4 2016	Oct 27, 2016	$-0.26	$-0.37	-42.3%	✗ MISS
Q2 2016	May 11, 2016	$-0.41	$-0.38	+7.3%	✓ BEAT
Q4 2015	Nov 4, 2015	$-0.53	$-0.45	+15.1%	✓ BEAT
Q3 2015	Jul 27, 2015	$-0.55	$-0.51	+7.3%	✓ BEAT
Q2 2015	May 11, 2015	$-0.58	$-0.59	-1.7%	✗ MISS
Q4 2014	Oct 29, 2014	$-0.70	$-0.52	+25.7%	✓ BEAT
Q3 2014	Aug 11, 2014	—	—	—	—

Frequently Asked Questions about EVARF

What is EVARF's current stock price?

Lombard Medical, Inc. (EVARF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for EVARF?

No analyst price targets are currently available for this stock.

What sector is Lombard Medical, Inc. in?

Lombard Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is EVARF's market cap?

Lombard Medical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does EVARF pay dividends?

No, Lombard Medical, Inc. does not currently pay a dividend to shareholders.